Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Index by author

November 01, 2021; Volume 18,Issue 4
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

B

  1. Bai, Rilan

    1. You have access
      Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
      Rilan Bai, Naifei Chen, Xiao Chen, Lingyu Li, Wei Song, Wei Li, Yuguang Zhao, Yongfei Zhang, Fujun Han, Zheng Lyu and Jiuwei Cui
      Cancer Biology & Medicine November 2021, 18 (4) 1118-1133; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0052
  2. Bai, Xueli

    1. You have access
      Multiplex imaging reveals the architecture of the tumor immune microenvironment
      Junlei Zhang, Jinyuan Song, Jianpeng Sheng, Xueli Bai and Tingbo Liang
      Cancer Biology & Medicine November 2021, 18 (4) 949-954; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0494

C

  1. Chen, Fengyang

    1. You have access
      Cyclophosphamide abrogates the expansion of CD4+Foxp3+ regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas
      Ping Li, Fengyang Chen, Jingbin Zheng, Yang Yang, Yuan Li, Yifei Wang and Xin Chen
      Cancer Biology & Medicine November 2021, 18 (4) 1010-1020; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0027
  2. Chen, Huijing

    1. You have access
      Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
      Huahui Yu, Jieyu Li, Yuan Yuan, Yu Chen, Jingwen Hong, Chunmei Ye, Wansong Lin, Huijing Chen, Zengqing Guo, Bo Li and Yunbin Ye
      Cancer Biology & Medicine November 2021, 18 (4) 1053-1065; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0022
  3. Chen, Naifei

    1. You have access
      Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
      Rilan Bai, Naifei Chen, Xiao Chen, Lingyu Li, Wei Song, Wei Li, Yuguang Zhao, Yongfei Zhang, Fujun Han, Zheng Lyu and Jiuwei Cui
      Cancer Biology & Medicine November 2021, 18 (4) 1118-1133; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0052
  4. Chen, Xiao

    1. You have access
      Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
      Rilan Bai, Naifei Chen, Xiao Chen, Lingyu Li, Wei Song, Wei Li, Yuguang Zhao, Yongfei Zhang, Fujun Han, Zheng Lyu and Jiuwei Cui
      Cancer Biology & Medicine November 2021, 18 (4) 1118-1133; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0052
  5. Chen, Xiaobing

    1. You have access
      Epithelial cells mimic immune cells: a novel path toward tumor immunotherapy
      Ruining Gong, Yan Huang, Xiaoxuan Wang, Xiaobing Chen, Zibin Tian and He Ren
      Cancer Biology & Medicine November 2021, 18 (4) 937-939; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0406
  6. Chen, Xin

    1. You have access
      Cyclophosphamide abrogates the expansion of CD4+Foxp3+ regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas
      Ping Li, Fengyang Chen, Jingbin Zheng, Yang Yang, Yuan Li, Yifei Wang and Xin Chen
      Cancer Biology & Medicine November 2021, 18 (4) 1010-1020; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0027
  7. Chen, Yu

    1. You have access
      Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
      Huahui Yu, Jieyu Li, Yuan Yuan, Yu Chen, Jingwen Hong, Chunmei Ye, Wansong Lin, Huijing Chen, Zengqing Guo, Bo Li and Yunbin Ye
      Cancer Biology & Medicine November 2021, 18 (4) 1053-1065; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0022
  8. Cui, Jiuwei

    1. You have access
      Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
      Rilan Bai, Naifei Chen, Xiao Chen, Lingyu Li, Wei Song, Wei Li, Yuguang Zhao, Yongfei Zhang, Fujun Han, Zheng Lyu and Jiuwei Cui
      Cancer Biology & Medicine November 2021, 18 (4) 1118-1133; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0052

D

  1. Du, Weijiao

    1. You have access
      Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
      Weihong Zhang, Yuan Meng, Lin Yang, Meng Shen, Li Zhou, Runmei Li, Yang Wang, Weijiao Du, Yanjuan Xiong, Ying Han, Xinwei Zhang, Liang Liu and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1109-1117; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0037

F

  1. Fan, Jia

    1. You have access
      Single-cell RNA sequencing reveals spatial heterogeneity and immune evasion of circulating tumor cells
      Yunfan Sun, Jian Zhou, Jia Fan and Xinrong Yang
      Cancer Biology & Medicine November 2021, 18 (4) 934-936; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0466

G

  1. Gao, Quanli

    1. You have access
      Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies
      Lu Han, Jian Zhou, Linlin Li, Keshu Zhou, Lingdi Zhao, Xinghu Zhu, Qingsong Yin, Yufu Li, Hongqin You, Jishuai Zhang, Yongping Song and Quanli Gao
      Cancer Biology & Medicine November 2021, 18 (4) 1066-1079; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0040
  2. Gong, Ruining

    1. You have access
      Epithelial cells mimic immune cells: a novel path toward tumor immunotherapy
      Ruining Gong, Yan Huang, Xiaoxuan Wang, Xiaobing Chen, Zibin Tian and He Ren
      Cancer Biology & Medicine November 2021, 18 (4) 937-939; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0406
  3. Gong, Zhe

    1. You have access
      Evaluation of 30 DNA damage response and 6 mismatch repair gene mutations as biomarkers for immunotherapy outcomes across multiple solid tumor types
      Zhe Gong, Yue Yang, Jieyun Zhang and Weijian Guo
      Cancer Biology & Medicine November 2021, 18 (4) 1080-1091; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0351
  4. Guo, Weijian

    1. You have access
      Evaluation of 30 DNA damage response and 6 mismatch repair gene mutations as biomarkers for immunotherapy outcomes across multiple solid tumor types
      Zhe Gong, Yue Yang, Jieyun Zhang and Weijian Guo
      Cancer Biology & Medicine November 2021, 18 (4) 1080-1091; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0351
  5. Guo, Zengqing

    1. You have access
      Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
      Huahui Yu, Jieyu Li, Yuan Yuan, Yu Chen, Jingwen Hong, Chunmei Ye, Wansong Lin, Huijing Chen, Zengqing Guo, Bo Li and Yunbin Ye
      Cancer Biology & Medicine November 2021, 18 (4) 1053-1065; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0022

H

  1. Han, Fujun

    1. You have access
      Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
      Rilan Bai, Naifei Chen, Xiao Chen, Lingyu Li, Wei Song, Wei Li, Yuguang Zhao, Yongfei Zhang, Fujun Han, Zheng Lyu and Jiuwei Cui
      Cancer Biology & Medicine November 2021, 18 (4) 1118-1133; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0052
  2. Han, Lu

    1. You have access
      Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies
      Lu Han, Jian Zhou, Linlin Li, Keshu Zhou, Lingdi Zhao, Xinghu Zhu, Qingsong Yin, Yufu Li, Hongqin You, Jishuai Zhang, Yongping Song and Quanli Gao
      Cancer Biology & Medicine November 2021, 18 (4) 1066-1079; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0040
  3. Han, Ying

    1. You have access
      Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
      Weihong Zhang, Yuan Meng, Lin Yang, Meng Shen, Li Zhou, Runmei Li, Yang Wang, Weijiao Du, Yanjuan Xiong, Ying Han, Xinwei Zhang, Liang Liu and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1109-1117; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0037
  4. Hao, Xuezhi

    1. You have access
      The commensal consortium of the gut microbiome is associated with favorable responses to anti-programmed death protein 1 (PD-1) therapy in thoracic neoplasms
      Huihui Yin, Lu Yang, Gongxin Peng, Ke Yang, Yuling Mi, Xingsheng Hu, Xuezhi Hao, Yuchen Jiao, Xiaobing Wang and Yan Wang
      Cancer Biology & Medicine November 2021, 18 (4) 1040-1052; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0450
  5. Hong, Jingwen

    1. You have access
      Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
      Huahui Yu, Jieyu Li, Yuan Yuan, Yu Chen, Jingwen Hong, Chunmei Ye, Wansong Lin, Huijing Chen, Zengqing Guo, Bo Li and Yunbin Ye
      Cancer Biology & Medicine November 2021, 18 (4) 1053-1065; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0022
  6. Hu, Jiajian

    1. You have access
      EZH2 identifies the precursors of human natural killer cells with trained immunity
      Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791
  7. Hu, Xingsheng

    1. You have access
      The commensal consortium of the gut microbiome is associated with favorable responses to anti-programmed death protein 1 (PD-1) therapy in thoracic neoplasms
      Huihui Yin, Lu Yang, Gongxin Peng, Ke Yang, Yuling Mi, Xingsheng Hu, Xuezhi Hao, Yuchen Jiao, Xiaobing Wang and Yan Wang
      Cancer Biology & Medicine November 2021, 18 (4) 1040-1052; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0450
  8. Huang, Xiaojun

    1. You have access
      Cellular immunotherapy for hematological malignancy: recent progress and future perspectives
      Zhengli Xu and Xiaojun Huang
      Cancer Biology & Medicine November 2021, 18 (4) 966-980; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0801
  9. Huang, Yan

    1. You have access
      Epithelial cells mimic immune cells: a novel path toward tumor immunotherapy
      Ruining Gong, Yan Huang, Xiaoxuan Wang, Xiaobing Chen, Zibin Tian and He Ren
      Cancer Biology & Medicine November 2021, 18 (4) 937-939; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0406
  10. Huang, Yuhui

    1. You have access
      The role of DLL1 in long-term vascular normalization and cancer immunotherapy
      Qiaozhen Wu and Yuhui Huang
      Cancer Biology & Medicine November 2021, 18 (4) 940-943; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0507

J

  1. Jiao, Yuchen

    1. You have access
      The commensal consortium of the gut microbiome is associated with favorable responses to anti-programmed death protein 1 (PD-1) therapy in thoracic neoplasms
      Huihui Yin, Lu Yang, Gongxin Peng, Ke Yang, Yuling Mi, Xingsheng Hu, Xuezhi Hao, Yuchen Jiao, Xiaobing Wang and Yan Wang
      Cancer Biology & Medicine November 2021, 18 (4) 1040-1052; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0450
  2. Jin, Yanxia

    1. You have access
      Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver
      Xiangdong Ye, Xueqing Wang, Wenhui Yu, Qing Yang, Yan Li, Yanxia Jin, Yanting Su, Jiaqi Song, Bo Xu and Hui Sun
      Cancer Biology & Medicine November 2021, 18 (4) 1092-1108; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0278

K

  1. Kiyotani, Kazuma

    1. You have access
      Personalized immunotherapy in cancer precision medicine
      Kazuma Kiyotani, Yujiro Toyoshima and Yusuke Nakamura
      Cancer Biology & Medicine November 2021, 18 (4) 955-965; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0032

L

  1. Li, Bo

    1. You have access
      Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
      Huahui Yu, Jieyu Li, Yuan Yuan, Yu Chen, Jingwen Hong, Chunmei Ye, Wansong Lin, Huijing Chen, Zengqing Guo, Bo Li and Yunbin Ye
      Cancer Biology & Medicine November 2021, 18 (4) 1053-1065; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0022
  2. Li, Hao

    1. You have access
      Targeting myeloid-derived suppressor cells for cancer therapy
      Hongchao Tang, Hao Li and Zhijun Sun
      Cancer Biology & Medicine November 2021, 18 (4) 992-1009; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0806
  3. Li, Jieyu

    1. You have access
      Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
      Huahui Yu, Jieyu Li, Yuan Yuan, Yu Chen, Jingwen Hong, Chunmei Ye, Wansong Lin, Huijing Chen, Zengqing Guo, Bo Li and Yunbin Ye
      Cancer Biology & Medicine November 2021, 18 (4) 1053-1065; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0022
  4. Li, Lingyu

    1. You have access
      Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
      Rilan Bai, Naifei Chen, Xiao Chen, Lingyu Li, Wei Song, Wei Li, Yuguang Zhao, Yongfei Zhang, Fujun Han, Zheng Lyu and Jiuwei Cui
      Cancer Biology & Medicine November 2021, 18 (4) 1118-1133; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0052
  5. Li, Linlin

    1. You have access
      Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies
      Lu Han, Jian Zhou, Linlin Li, Keshu Zhou, Lingdi Zhao, Xinghu Zhu, Qingsong Yin, Yufu Li, Hongqin You, Jishuai Zhang, Yongping Song and Quanli Gao
      Cancer Biology & Medicine November 2021, 18 (4) 1066-1079; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0040
  6. Li, Long

    1. You have access
      EZH2 identifies the precursors of human natural killer cells with trained immunity
      Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791
  7. Li, Ping

    1. You have access
      Cyclophosphamide abrogates the expansion of CD4+Foxp3+ regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas
      Ping Li, Fengyang Chen, Jingbin Zheng, Yang Yang, Yuan Li, Yifei Wang and Xin Chen
      Cancer Biology & Medicine November 2021, 18 (4) 1010-1020; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0027
  8. Li, Runmei

    1. You have access
      Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
      Weihong Zhang, Yuan Meng, Lin Yang, Meng Shen, Li Zhou, Runmei Li, Yang Wang, Weijiao Du, Yanjuan Xiong, Ying Han, Xinwei Zhang, Liang Liu and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1109-1117; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0037
  9. Li, Wei

    1. You have access
      Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
      Rilan Bai, Naifei Chen, Xiao Chen, Lingyu Li, Wei Song, Wei Li, Yuguang Zhao, Yongfei Zhang, Fujun Han, Zheng Lyu and Jiuwei Cui
      Cancer Biology & Medicine November 2021, 18 (4) 1118-1133; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0052
  10. Li, Yan

    1. You have access
      Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver
      Xiangdong Ye, Xueqing Wang, Wenhui Yu, Qing Yang, Yan Li, Yanxia Jin, Yanting Su, Jiaqi Song, Bo Xu and Hui Sun
      Cancer Biology & Medicine November 2021, 18 (4) 1092-1108; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0278
  11. Li, Yuan

    1. You have access
      Cyclophosphamide abrogates the expansion of CD4+Foxp3+ regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas
      Ping Li, Fengyang Chen, Jingbin Zheng, Yang Yang, Yuan Li, Yifei Wang and Xin Chen
      Cancer Biology & Medicine November 2021, 18 (4) 1010-1020; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0027
  12. Li, Yufu

    1. You have access
      Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies
      Lu Han, Jian Zhou, Linlin Li, Keshu Zhou, Lingdi Zhao, Xinghu Zhu, Qingsong Yin, Yufu Li, Hongqin You, Jishuai Zhang, Yongping Song and Quanli Gao
      Cancer Biology & Medicine November 2021, 18 (4) 1066-1079; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0040
  13. Liang, Tingbo

    1. You have access
      Multiplex imaging reveals the architecture of the tumor immune microenvironment
      Junlei Zhang, Jinyuan Song, Jianpeng Sheng, Xueli Bai and Tingbo Liang
      Cancer Biology & Medicine November 2021, 18 (4) 949-954; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0494
  14. Lin, Wansong

    1. You have access
      Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
      Huahui Yu, Jieyu Li, Yuan Yuan, Yu Chen, Jingwen Hong, Chunmei Ye, Wansong Lin, Huijing Chen, Zengqing Guo, Bo Li and Yunbin Ye
      Cancer Biology & Medicine November 2021, 18 (4) 1053-1065; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0022
  15. Liu, Liang

    1. You have access
      Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
      Weihong Zhang, Yuan Meng, Lin Yang, Meng Shen, Li Zhou, Runmei Li, Yang Wang, Weijiao Du, Yanjuan Xiong, Ying Han, Xinwei Zhang, Liang Liu and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1109-1117; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0037
  16. Liu, Min

    1. You have access
      The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma
      Jian Wang, Fan Yang, Qian Sun, Ziqing Zeng, Min Liu, Wenwen Yu, Peng Zhang, Jinpu Yu, Lili Yang, Xinwei Zhang, Xiubao Ren and Feng Wei
      Cancer Biology & Medicine November 2021, 18 (4) 1134-1147; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0023
  17. Lyu, Zheng

    1. You have access
      Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
      Rilan Bai, Naifei Chen, Xiao Chen, Lingyu Li, Wei Song, Wei Li, Yuguang Zhao, Yongfei Zhang, Fujun Han, Zheng Lyu and Jiuwei Cui
      Cancer Biology & Medicine November 2021, 18 (4) 1118-1133; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0052

M

  1. Meng, Yuan

    1. You have access
      Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
      Weihong Zhang, Yuan Meng, Lin Yang, Meng Shen, Li Zhou, Runmei Li, Yang Wang, Weijiao Du, Yanjuan Xiong, Ying Han, Xinwei Zhang, Liang Liu and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1109-1117; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0037
  2. Mi, Yuling

    1. You have access
      The commensal consortium of the gut microbiome is associated with favorable responses to anti-programmed death protein 1 (PD-1) therapy in thoracic neoplasms
      Huihui Yin, Lu Yang, Gongxin Peng, Ke Yang, Yuling Mi, Xingsheng Hu, Xuezhi Hao, Yuchen Jiao, Xiaobing Wang and Yan Wang
      Cancer Biology & Medicine November 2021, 18 (4) 1040-1052; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0450

N

  1. Nakamura, Yusuke

    1. You have access
      Personalized immunotherapy in cancer precision medicine
      Kazuma Kiyotani, Yujiro Toyoshima and Yusuke Nakamura
      Cancer Biology & Medicine November 2021, 18 (4) 955-965; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0032

P

  1. Peng, Gongxin

    1. You have access
      The commensal consortium of the gut microbiome is associated with favorable responses to anti-programmed death protein 1 (PD-1) therapy in thoracic neoplasms
      Huihui Yin, Lu Yang, Gongxin Peng, Ke Yang, Yuling Mi, Xingsheng Hu, Xuezhi Hao, Yuchen Jiao, Xiaobing Wang and Yan Wang
      Cancer Biology & Medicine November 2021, 18 (4) 1040-1052; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0450

R

  1. Ren, He

    1. You have access
      Epithelial cells mimic immune cells: a novel path toward tumor immunotherapy
      Ruining Gong, Yan Huang, Xiaoxuan Wang, Xiaobing Chen, Zibin Tian and He Ren
      Cancer Biology & Medicine November 2021, 18 (4) 937-939; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0406
  2. Ren, Xiubao

    1. You have access
      Cancer immunology and immunotherapy
      Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 931-933; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0036
    2. You have access
      Insights into tertiary lymphoid structures in the solid tumor microenvironment: anti-tumor mechanism, functional regulation, and immunotherapeutic strategies
      Hua Zhao, Hao Wang, Qiuru Zhou and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 981-991; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0029
    3. You have access
      EZH2 identifies the precursors of human natural killer cells with trained immunity
      Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791
    4. You have access
      Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
      Weihong Zhang, Yuan Meng, Lin Yang, Meng Shen, Li Zhou, Runmei Li, Yang Wang, Weijiao Du, Yanjuan Xiong, Ying Han, Xinwei Zhang, Liang Liu and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1109-1117; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0037
    5. You have access
      The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma
      Jian Wang, Fan Yang, Qian Sun, Ziqing Zeng, Min Liu, Wenwen Yu, Peng Zhang, Jinpu Yu, Lili Yang, Xinwei Zhang, Xiubao Ren and Feng Wei
      Cancer Biology & Medicine November 2021, 18 (4) 1134-1147; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0023

S

  1. Shen, Meng

    1. You have access
      Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
      Weihong Zhang, Yuan Meng, Lin Yang, Meng Shen, Li Zhou, Runmei Li, Yang Wang, Weijiao Du, Yanjuan Xiong, Ying Han, Xinwei Zhang, Liang Liu and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1109-1117; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0037
  2. Sheng, Jianpeng

    1. You have access
      Multiplex imaging reveals the architecture of the tumor immune microenvironment
      Junlei Zhang, Jinyuan Song, Jianpeng Sheng, Xueli Bai and Tingbo Liang
      Cancer Biology & Medicine November 2021, 18 (4) 949-954; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0494
  3. Song, Jiaqi

    1. You have access
      Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver
      Xiangdong Ye, Xueqing Wang, Wenhui Yu, Qing Yang, Yan Li, Yanxia Jin, Yanting Su, Jiaqi Song, Bo Xu and Hui Sun
      Cancer Biology & Medicine November 2021, 18 (4) 1092-1108; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0278
  4. Song, Jinyuan

    1. You have access
      Multiplex imaging reveals the architecture of the tumor immune microenvironment
      Junlei Zhang, Jinyuan Song, Jianpeng Sheng, Xueli Bai and Tingbo Liang
      Cancer Biology & Medicine November 2021, 18 (4) 949-954; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0494
  5. Song, Wei

    1. You have access
      Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
      Rilan Bai, Naifei Chen, Xiao Chen, Lingyu Li, Wei Song, Wei Li, Yuguang Zhao, Yongfei Zhang, Fujun Han, Zheng Lyu and Jiuwei Cui
      Cancer Biology & Medicine November 2021, 18 (4) 1118-1133; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0052
  6. Song, Yongping

    1. You have access
      Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies
      Lu Han, Jian Zhou, Linlin Li, Keshu Zhou, Lingdi Zhao, Xinghu Zhu, Qingsong Yin, Yufu Li, Hongqin You, Jishuai Zhang, Yongping Song and Quanli Gao
      Cancer Biology & Medicine November 2021, 18 (4) 1066-1079; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0040
  7. Su, Yanting

    1. You have access
      Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver
      Xiangdong Ye, Xueqing Wang, Wenhui Yu, Qing Yang, Yan Li, Yanxia Jin, Yanting Su, Jiaqi Song, Bo Xu and Hui Sun
      Cancer Biology & Medicine November 2021, 18 (4) 1092-1108; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0278
  8. Su, Yudong

    1. You have access
      EZH2 identifies the precursors of human natural killer cells with trained immunity
      Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791
  9. Sun, Hui

    1. You have access
      Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver
      Xiangdong Ye, Xueqing Wang, Wenhui Yu, Qing Yang, Yan Li, Yanxia Jin, Yanting Su, Jiaqi Song, Bo Xu and Hui Sun
      Cancer Biology & Medicine November 2021, 18 (4) 1092-1108; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0278
  10. Sun, Qian

    1. You have access
      EZH2 identifies the precursors of human natural killer cells with trained immunity
      Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791
    2. You have access
      The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma
      Jian Wang, Fan Yang, Qian Sun, Ziqing Zeng, Min Liu, Wenwen Yu, Peng Zhang, Jinpu Yu, Lili Yang, Xinwei Zhang, Xiubao Ren and Feng Wei
      Cancer Biology & Medicine November 2021, 18 (4) 1134-1147; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0023
  11. Sun, Yunfan

    1. You have access
      Single-cell RNA sequencing reveals spatial heterogeneity and immune evasion of circulating tumor cells
      Yunfan Sun, Jian Zhou, Jia Fan and Xinrong Yang
      Cancer Biology & Medicine November 2021, 18 (4) 934-936; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0466
  12. Sun, Zhijun

    1. You have access
      Targeting myeloid-derived suppressor cells for cancer therapy
      Hongchao Tang, Hao Li and Zhijun Sun
      Cancer Biology & Medicine November 2021, 18 (4) 992-1009; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0806

T

  1. Tang, Hongchao

    1. You have access
      Targeting myeloid-derived suppressor cells for cancer therapy
      Hongchao Tang, Hao Li and Zhijun Sun
      Cancer Biology & Medicine November 2021, 18 (4) 992-1009; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0806
  2. Tian, Zibin

    1. You have access
      Epithelial cells mimic immune cells: a novel path toward tumor immunotherapy
      Ruining Gong, Yan Huang, Xiaoxuan Wang, Xiaobing Chen, Zibin Tian and He Ren
      Cancer Biology & Medicine November 2021, 18 (4) 937-939; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0406
  3. Toyoshima, Yujiro

    1. You have access
      Personalized immunotherapy in cancer precision medicine
      Kazuma Kiyotani, Yujiro Toyoshima and Yusuke Nakamura
      Cancer Biology & Medicine November 2021, 18 (4) 955-965; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0032

W

  1. Wang, Hao

    1. You have access
      Insights into tertiary lymphoid structures in the solid tumor microenvironment: anti-tumor mechanism, functional regulation, and immunotherapeutic strategies
      Hua Zhao, Hao Wang, Qiuru Zhou and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 981-991; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0029
  2. Wang, Jian

    1. You have access
      The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma
      Jian Wang, Fan Yang, Qian Sun, Ziqing Zeng, Min Liu, Wenwen Yu, Peng Zhang, Jinpu Yu, Lili Yang, Xinwei Zhang, Xiubao Ren and Feng Wei
      Cancer Biology & Medicine November 2021, 18 (4) 1134-1147; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0023
  3. Wang, Xiaobing

    1. You have access
      The commensal consortium of the gut microbiome is associated with favorable responses to anti-programmed death protein 1 (PD-1) therapy in thoracic neoplasms
      Huihui Yin, Lu Yang, Gongxin Peng, Ke Yang, Yuling Mi, Xingsheng Hu, Xuezhi Hao, Yuchen Jiao, Xiaobing Wang and Yan Wang
      Cancer Biology & Medicine November 2021, 18 (4) 1040-1052; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0450
  4. Wang, Xiaoxuan

    1. You have access
      Epithelial cells mimic immune cells: a novel path toward tumor immunotherapy
      Ruining Gong, Yan Huang, Xiaoxuan Wang, Xiaobing Chen, Zibin Tian and He Ren
      Cancer Biology & Medicine November 2021, 18 (4) 937-939; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0406
  5. Wang, Xueqing

    1. You have access
      Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver
      Xiangdong Ye, Xueqing Wang, Wenhui Yu, Qing Yang, Yan Li, Yanxia Jin, Yanting Su, Jiaqi Song, Bo Xu and Hui Sun
      Cancer Biology & Medicine November 2021, 18 (4) 1092-1108; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0278
  6. Wang, Yan

    1. You have access
      The commensal consortium of the gut microbiome is associated with favorable responses to anti-programmed death protein 1 (PD-1) therapy in thoracic neoplasms
      Huihui Yin, Lu Yang, Gongxin Peng, Ke Yang, Yuling Mi, Xingsheng Hu, Xuezhi Hao, Yuchen Jiao, Xiaobing Wang and Yan Wang
      Cancer Biology & Medicine November 2021, 18 (4) 1040-1052; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0450
  7. Wang, Yang

    1. You have access
      EZH2 identifies the precursors of human natural killer cells with trained immunity
      Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791
    2. You have access
      Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
      Weihong Zhang, Yuan Meng, Lin Yang, Meng Shen, Li Zhou, Runmei Li, Yang Wang, Weijiao Du, Yanjuan Xiong, Ying Han, Xinwei Zhang, Liang Liu and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1109-1117; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0037
  8. Wang, Yifei

    1. You have access
      Cyclophosphamide abrogates the expansion of CD4+Foxp3+ regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas
      Ping Li, Fengyang Chen, Jingbin Zheng, Yang Yang, Yuan Li, Yifei Wang and Xin Chen
      Cancer Biology & Medicine November 2021, 18 (4) 1010-1020; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0027
  9. Wei, Feng

    1. You have access
      EZH2 identifies the precursors of human natural killer cells with trained immunity
      Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791
    2. You have access
      The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma
      Jian Wang, Fan Yang, Qian Sun, Ziqing Zeng, Min Liu, Wenwen Yu, Peng Zhang, Jinpu Yu, Lili Yang, Xinwei Zhang, Xiubao Ren and Feng Wei
      Cancer Biology & Medicine November 2021, 18 (4) 1134-1147; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0023
  10. Wu, Qiaozhen

    1. You have access
      The role of DLL1 in long-term vascular normalization and cancer immunotherapy
      Qiaozhen Wu and Yuhui Huang
      Cancer Biology & Medicine November 2021, 18 (4) 940-943; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0507

X

  1. Xiao, Jun

    1. You have access
      EZH2 identifies the precursors of human natural killer cells with trained immunity
      Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791
  2. Xiong, Yanjuan

    1. You have access
      Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
      Weihong Zhang, Yuan Meng, Lin Yang, Meng Shen, Li Zhou, Runmei Li, Yang Wang, Weijiao Du, Yanjuan Xiong, Ying Han, Xinwei Zhang, Liang Liu and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1109-1117; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0037
  3. Xu, Bo

    1. You have access
      Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver
      Xiangdong Ye, Xueqing Wang, Wenhui Yu, Qing Yang, Yan Li, Yanxia Jin, Yanting Su, Jiaqi Song, Bo Xu and Hui Sun
      Cancer Biology & Medicine November 2021, 18 (4) 1092-1108; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0278
  4. Xu, Zhengli

    1. You have access
      Cellular immunotherapy for hematological malignancy: recent progress and future perspectives
      Zhengli Xu and Xiaojun Huang
      Cancer Biology & Medicine November 2021, 18 (4) 966-980; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0801

Y

  1. Yang, Fan

    1. You have access
      The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma
      Jian Wang, Fan Yang, Qian Sun, Ziqing Zeng, Min Liu, Wenwen Yu, Peng Zhang, Jinpu Yu, Lili Yang, Xinwei Zhang, Xiubao Ren and Feng Wei
      Cancer Biology & Medicine November 2021, 18 (4) 1134-1147; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0023
  2. Yang, Ke

    1. You have access
      The commensal consortium of the gut microbiome is associated with favorable responses to anti-programmed death protein 1 (PD-1) therapy in thoracic neoplasms
      Huihui Yin, Lu Yang, Gongxin Peng, Ke Yang, Yuling Mi, Xingsheng Hu, Xuezhi Hao, Yuchen Jiao, Xiaobing Wang and Yan Wang
      Cancer Biology & Medicine November 2021, 18 (4) 1040-1052; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0450
  3. Yang, Lili

    1. You have access
      The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma
      Jian Wang, Fan Yang, Qian Sun, Ziqing Zeng, Min Liu, Wenwen Yu, Peng Zhang, Jinpu Yu, Lili Yang, Xinwei Zhang, Xiubao Ren and Feng Wei
      Cancer Biology & Medicine November 2021, 18 (4) 1134-1147; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0023
  4. Yang, Lin

    1. You have access
      Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
      Weihong Zhang, Yuan Meng, Lin Yang, Meng Shen, Li Zhou, Runmei Li, Yang Wang, Weijiao Du, Yanjuan Xiong, Ying Han, Xinwei Zhang, Liang Liu and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1109-1117; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0037
  5. Yang, Lu

    1. You have access
      The commensal consortium of the gut microbiome is associated with favorable responses to anti-programmed death protein 1 (PD-1) therapy in thoracic neoplasms
      Huihui Yin, Lu Yang, Gongxin Peng, Ke Yang, Yuling Mi, Xingsheng Hu, Xuezhi Hao, Yuchen Jiao, Xiaobing Wang and Yan Wang
      Cancer Biology & Medicine November 2021, 18 (4) 1040-1052; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0450
  6. Yang, Qing

    1. You have access
      Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver
      Xiangdong Ye, Xueqing Wang, Wenhui Yu, Qing Yang, Yan Li, Yanxia Jin, Yanting Su, Jiaqi Song, Bo Xu and Hui Sun
      Cancer Biology & Medicine November 2021, 18 (4) 1092-1108; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0278
  7. Yang, Xinrong

    1. You have access
      Single-cell RNA sequencing reveals spatial heterogeneity and immune evasion of circulating tumor cells
      Yunfan Sun, Jian Zhou, Jia Fan and Xinrong Yang
      Cancer Biology & Medicine November 2021, 18 (4) 934-936; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0466
  8. Yang, Yang

    1. You have access
      Cyclophosphamide abrogates the expansion of CD4+Foxp3+ regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas
      Ping Li, Fengyang Chen, Jingbin Zheng, Yang Yang, Yuan Li, Yifei Wang and Xin Chen
      Cancer Biology & Medicine November 2021, 18 (4) 1010-1020; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0027
  9. Yang, Yue

    1. You have access
      Evaluation of 30 DNA damage response and 6 mismatch repair gene mutations as biomarkers for immunotherapy outcomes across multiple solid tumor types
      Zhe Gong, Yue Yang, Jieyun Zhang and Weijian Guo
      Cancer Biology & Medicine November 2021, 18 (4) 1080-1091; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0351
  10. Ye, Chunmei

    1. You have access
      Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
      Huahui Yu, Jieyu Li, Yuan Yuan, Yu Chen, Jingwen Hong, Chunmei Ye, Wansong Lin, Huijing Chen, Zengqing Guo, Bo Li and Yunbin Ye
      Cancer Biology & Medicine November 2021, 18 (4) 1053-1065; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0022
  11. Ye, Xiangdong

    1. You have access
      Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver
      Xiangdong Ye, Xueqing Wang, Wenhui Yu, Qing Yang, Yan Li, Yanxia Jin, Yanting Su, Jiaqi Song, Bo Xu and Hui Sun
      Cancer Biology & Medicine November 2021, 18 (4) 1092-1108; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0278
  12. Ye, Yunbin

    1. You have access
      Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
      Huahui Yu, Jieyu Li, Yuan Yuan, Yu Chen, Jingwen Hong, Chunmei Ye, Wansong Lin, Huijing Chen, Zengqing Guo, Bo Li and Yunbin Ye
      Cancer Biology & Medicine November 2021, 18 (4) 1053-1065; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0022
  13. Yin, Huihui

    1. You have access
      The commensal consortium of the gut microbiome is associated with favorable responses to anti-programmed death protein 1 (PD-1) therapy in thoracic neoplasms
      Huihui Yin, Lu Yang, Gongxin Peng, Ke Yang, Yuling Mi, Xingsheng Hu, Xuezhi Hao, Yuchen Jiao, Xiaobing Wang and Yan Wang
      Cancer Biology & Medicine November 2021, 18 (4) 1040-1052; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0450
  14. Yin, Jie

    1. You have access
      EZH2 identifies the precursors of human natural killer cells with trained immunity
      Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791
  15. Yin, Qingsong

    1. You have access
      Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies
      Lu Han, Jian Zhou, Linlin Li, Keshu Zhou, Lingdi Zhao, Xinghu Zhu, Qingsong Yin, Yufu Li, Hongqin You, Jishuai Zhang, Yongping Song and Quanli Gao
      Cancer Biology & Medicine November 2021, 18 (4) 1066-1079; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0040
  16. You, Hongqin

    1. You have access
      Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies
      Lu Han, Jian Zhou, Linlin Li, Keshu Zhou, Lingdi Zhao, Xinghu Zhu, Qingsong Yin, Yufu Li, Hongqin You, Jishuai Zhang, Yongping Song and Quanli Gao
      Cancer Biology & Medicine November 2021, 18 (4) 1066-1079; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0040
  17. Yu, Huahui

    1. You have access
      Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
      Huahui Yu, Jieyu Li, Yuan Yuan, Yu Chen, Jingwen Hong, Chunmei Ye, Wansong Lin, Huijing Chen, Zengqing Guo, Bo Li and Yunbin Ye
      Cancer Biology & Medicine November 2021, 18 (4) 1053-1065; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0022
  18. Yu, Jinpu

    1. You have access
      The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma
      Jian Wang, Fan Yang, Qian Sun, Ziqing Zeng, Min Liu, Wenwen Yu, Peng Zhang, Jinpu Yu, Lili Yang, Xinwei Zhang, Xiubao Ren and Feng Wei
      Cancer Biology & Medicine November 2021, 18 (4) 1134-1147; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0023
  19. Yu, Wenhui

    1. You have access
      Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver
      Xiangdong Ye, Xueqing Wang, Wenhui Yu, Qing Yang, Yan Li, Yanxia Jin, Yanting Su, Jiaqi Song, Bo Xu and Hui Sun
      Cancer Biology & Medicine November 2021, 18 (4) 1092-1108; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0278
  20. Yu, Wenwen

    1. You have access
      EZH2 identifies the precursors of human natural killer cells with trained immunity
      Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791
    2. You have access
      The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma
      Jian Wang, Fan Yang, Qian Sun, Ziqing Zeng, Min Liu, Wenwen Yu, Peng Zhang, Jinpu Yu, Lili Yang, Xinwei Zhang, Xiubao Ren and Feng Wei
      Cancer Biology & Medicine November 2021, 18 (4) 1134-1147; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0023
  21. Yu, Yingyan

    1. You have access
      Repurposing glucocorticoids as adjuvant reagents for immune checkpoint inhibitors in solid cancers
      Yingyan Yu
      Cancer Biology & Medicine November 2021, 18 (4) 944-948; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0491
  22. Yuan, Yuan

    1. You have access
      Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
      Huahui Yu, Jieyu Li, Yuan Yuan, Yu Chen, Jingwen Hong, Chunmei Ye, Wansong Lin, Huijing Chen, Zengqing Guo, Bo Li and Yunbin Ye
      Cancer Biology & Medicine November 2021, 18 (4) 1053-1065; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0022

Z

  1. Zeng, Ziqing

    1. You have access
      The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma
      Jian Wang, Fan Yang, Qian Sun, Ziqing Zeng, Min Liu, Wenwen Yu, Peng Zhang, Jinpu Yu, Lili Yang, Xinwei Zhang, Xiubao Ren and Feng Wei
      Cancer Biology & Medicine November 2021, 18 (4) 1134-1147; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0023
  2. Zhang, Chen

    1. You have access
      EZH2 identifies the precursors of human natural killer cells with trained immunity
      Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791
  3. Zhang, Hong

    1. You have access
      EZH2 identifies the precursors of human natural killer cells with trained immunity
      Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791
  4. Zhang, Jieyun

    1. You have access
      Evaluation of 30 DNA damage response and 6 mismatch repair gene mutations as biomarkers for immunotherapy outcomes across multiple solid tumor types
      Zhe Gong, Yue Yang, Jieyun Zhang and Weijian Guo
      Cancer Biology & Medicine November 2021, 18 (4) 1080-1091; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0351
  5. Zhang, Jishuai

    1. You have access
      Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies
      Lu Han, Jian Zhou, Linlin Li, Keshu Zhou, Lingdi Zhao, Xinghu Zhu, Qingsong Yin, Yufu Li, Hongqin You, Jishuai Zhang, Yongping Song and Quanli Gao
      Cancer Biology & Medicine November 2021, 18 (4) 1066-1079; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0040
  6. Zhang, Junlei

    1. You have access
      Multiplex imaging reveals the architecture of the tumor immune microenvironment
      Junlei Zhang, Jinyuan Song, Jianpeng Sheng, Xueli Bai and Tingbo Liang
      Cancer Biology & Medicine November 2021, 18 (4) 949-954; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0494
  7. Zhang, Peng

    1. You have access
      The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma
      Jian Wang, Fan Yang, Qian Sun, Ziqing Zeng, Min Liu, Wenwen Yu, Peng Zhang, Jinpu Yu, Lili Yang, Xinwei Zhang, Xiubao Ren and Feng Wei
      Cancer Biology & Medicine November 2021, 18 (4) 1134-1147; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0023
  8. Zhang, Weihong

    1. You have access
      Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
      Weihong Zhang, Yuan Meng, Lin Yang, Meng Shen, Li Zhou, Runmei Li, Yang Wang, Weijiao Du, Yanjuan Xiong, Ying Han, Xinwei Zhang, Liang Liu and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1109-1117; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0037
  9. Zhang, Xinwei

    1. You have access
      Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
      Weihong Zhang, Yuan Meng, Lin Yang, Meng Shen, Li Zhou, Runmei Li, Yang Wang, Weijiao Du, Yanjuan Xiong, Ying Han, Xinwei Zhang, Liang Liu and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1109-1117; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0037
    2. You have access
      The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma
      Jian Wang, Fan Yang, Qian Sun, Ziqing Zeng, Min Liu, Wenwen Yu, Peng Zhang, Jinpu Yu, Lili Yang, Xinwei Zhang, Xiubao Ren and Feng Wei
      Cancer Biology & Medicine November 2021, 18 (4) 1134-1147; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0023
  10. Zhang, Xuzhen

    1. You have access
      EZH2 identifies the precursors of human natural killer cells with trained immunity
      Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791
  11. Zhang, Yingchi

    1. You have access
      EZH2 identifies the precursors of human natural killer cells with trained immunity
      Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791
  12. Zhang, Yongfei

    1. You have access
      Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
      Rilan Bai, Naifei Chen, Xiao Chen, Lingyu Li, Wei Song, Wei Li, Yuguang Zhao, Yongfei Zhang, Fujun Han, Zheng Lyu and Jiuwei Cui
      Cancer Biology & Medicine November 2021, 18 (4) 1118-1133; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0052
  13. Zhao, Hua

    1. You have access
      Insights into tertiary lymphoid structures in the solid tumor microenvironment: anti-tumor mechanism, functional regulation, and immunotherapeutic strategies
      Hua Zhao, Hao Wang, Qiuru Zhou and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 981-991; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0029
  14. Zhao, Lingdi

    1. You have access
      Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies
      Lu Han, Jian Zhou, Linlin Li, Keshu Zhou, Lingdi Zhao, Xinghu Zhu, Qingsong Yin, Yufu Li, Hongqin You, Jishuai Zhang, Yongping Song and Quanli Gao
      Cancer Biology & Medicine November 2021, 18 (4) 1066-1079; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0040
  15. Zhao, Qiang

    1. You have access
      EZH2 identifies the precursors of human natural killer cells with trained immunity
      Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791
  16. Zhao, Yuguang

    1. You have access
      Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
      Rilan Bai, Naifei Chen, Xiao Chen, Lingyu Li, Wei Song, Wei Li, Yuguang Zhao, Yongfei Zhang, Fujun Han, Zheng Lyu and Jiuwei Cui
      Cancer Biology & Medicine November 2021, 18 (4) 1118-1133; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0052
  17. Zheng, Jian

    1. You have access
      EZH2 identifies the precursors of human natural killer cells with trained immunity
      Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791
  18. Zheng, Jingbin

    1. You have access
      Cyclophosphamide abrogates the expansion of CD4+Foxp3+ regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas
      Ping Li, Fengyang Chen, Jingbin Zheng, Yang Yang, Yuan Li, Yifei Wang and Xin Chen
      Cancer Biology & Medicine November 2021, 18 (4) 1010-1020; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0027
  19. Zhou, Jian

    1. You have access
      Single-cell RNA sequencing reveals spatial heterogeneity and immune evasion of circulating tumor cells
      Yunfan Sun, Jian Zhou, Jia Fan and Xinrong Yang
      Cancer Biology & Medicine November 2021, 18 (4) 934-936; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0466
    2. You have access
      Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies
      Lu Han, Jian Zhou, Linlin Li, Keshu Zhou, Lingdi Zhao, Xinghu Zhu, Qingsong Yin, Yufu Li, Hongqin You, Jishuai Zhang, Yongping Song and Quanli Gao
      Cancer Biology & Medicine November 2021, 18 (4) 1066-1079; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0040
  20. Zhou, Kaichen

    1. You have access
      EZH2 identifies the precursors of human natural killer cells with trained immunity
      Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791
  21. Zhou, Keshu

    1. You have access
      Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies
      Lu Han, Jian Zhou, Linlin Li, Keshu Zhou, Lingdi Zhao, Xinghu Zhu, Qingsong Yin, Yufu Li, Hongqin You, Jishuai Zhang, Yongping Song and Quanli Gao
      Cancer Biology & Medicine November 2021, 18 (4) 1066-1079; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0040
  22. Zhou, Li

    1. You have access
      Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
      Weihong Zhang, Yuan Meng, Lin Yang, Meng Shen, Li Zhou, Runmei Li, Yang Wang, Weijiao Du, Yanjuan Xiong, Ying Han, Xinwei Zhang, Liang Liu and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 1109-1117; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0037
  23. Zhou, Qiuru

    1. You have access
      Insights into tertiary lymphoid structures in the solid tumor microenvironment: anti-tumor mechanism, functional regulation, and immunotherapeutic strategies
      Hua Zhao, Hao Wang, Qiuru Zhou and Xiubao Ren
      Cancer Biology & Medicine November 2021, 18 (4) 981-991; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0029
  24. Zhu, Xinghu

    1. You have access
      Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies
      Lu Han, Jian Zhou, Linlin Li, Keshu Zhou, Lingdi Zhao, Xinghu Zhu, Qingsong Yin, Yufu Li, Hongqin You, Jishuai Zhang, Yongping Song and Quanli Gao
      Cancer Biology & Medicine November 2021, 18 (4) 1066-1079; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0040
Back to top
PreviousNext

In this issue

Cancer Biology & Medicine: 18 (4)
Cancer Biology & Medicine
Vol. 18, Issue 4
1 Nov 2021
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

  • Top Topics
  • Most Cited
  • Most Read
Loading

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2022 Cancer Biology & Medicine

Powered by HighWire